行情

FBIOP

FBIOP

Fortress Biotech
NASDAQ

实时行情|Nasdaq Last Sale

20.95
-0.25
-1.19%
已收盘, 16:00 11/15 EST
开盘
21.20
昨收
21.20
最高
21.60
最低
20.60
成交量
1.88万
成交额
--
52周最高
21.95
52周最低
12.02
市值
14.46亿
市盈率(TTM)
-18.7411
分时
5日
1月
3月
1年
5年

FBIOP 新闻

  • 欧央行总裁拉加德承诺在决策出现意见分歧时寻求对话
  • 新浪财经综合.35分钟前
  • 微软宣布开放神经网络交换格式已加入Linux基金会
  • 新浪财经综合.37分钟前
  • 冰火两重天的瑞幸
  • 钛媒体.1小时前
  • 脸书假新闻太多 维基百科创始人办了一个新社交网络
  • 新浪财经综合.1小时前

更多

所属板块

制药
+1.26%
制药与医学研究
+1.27%

热门股票

名称
价格
涨跌幅

FBIOP 简况

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
展开

Webull提供Fortress Biotech Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。